Growth Metrics

TriSalus Life Sciences (TLSI) Current Taxes (2022 - 2023)

TriSalus Life Sciences posted quarterly Current Taxes of $30694.0 for Q2 2023, up 8.84% year-on-year from $28202.0 in Q2 2022, and down 44.16% on a QoQ basis from $54972.0 in Q1 2023.

TriSalus Life Sciences (TLSI) has 2 years of Current Taxes data on file, last reported at $30694.0 in Q2 2023.

  • For the quarter ending Q2 2023, Current Taxes rose 8.84% year-over-year to $30694.0; the trailing twelve-month figure through Jun 2023 stood at $30694.0 (up 8.84% YoY), and the FY2022 full-year result was $27854.0, changed N/A from the prior year.
  • Current Taxes for Q2 2023 stood at $30694.0, down from $54972.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $163486.0 in Q3 2022 and bottomed at $27854.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 598.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 476.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 650.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 231.81 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60 Mn
10 TriSalus Life Sciences 187.09 Mn 130.54 Mn 7.67 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 30,694.00
Mar 31, 2023 54,972.00
Dec 31, 2022 27,854.00
Sep 30, 2022 163,486.00
Jun 30, 2022 28,202.00